Finance

Beta
Ask
Lists
524572:BOM
Pharmaids Pharmaceuticals Ltd
₹32.17
-2.13%
(-0.70) 1D
Jun 19, 3:46:43 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524572...
Open
₹33.53
High
₹34.20
Low
₹31.50
Mkt. cap
1.13B
Avg. vol.
17.85K
Volume
13.82K
52-wk high
₹70.00
52-wk low
₹25.60
EPS
-₹3.31
Shares outstanding
3.41M
No. of employees
28
Open
₹33.53
High
₹34.20
Low
₹31.50
Mkt. cap
1.13B
Avg. vol.
17.85K
Volume
13.82K
52-wk high
₹70.00
52-wk low
₹25.60
EPS
-₹3.31
Shares outstanding
3.41M
No. of employees
28
News stories
From sources across the web
About Pharmaids Pharmaceuticals Ltd
CEO-
Employees28
Founded1989
Headquarters-
SectorPharmaceutical industry
Websitepharmaids.com
Last report
May 29, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
72.83M / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
66.64M
86.05M
54.30M
72.83M
Cost of goods sold
35.06M
75.50M
23.48M
37.48M
Cost of revenue
35.06M
75.50M
23.48M
37.48M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41.88M
31.81M
32.83M
27.26M
Operating expense
91.74M
68.44M
60.62M
42.52M
Total operating expenses
126.80M
143.95M
84.10M
80.00M
Operating income
-60.16M
-57.90M
-29.80M
-7.17M
Other non operating income
403.00K
2.22M
760.00K
1.00K
EBT including unusual items
-71.71M
-36.57M
-40.22M
-14.56M
EBT excluding unusual items
-71.71M
-66.45M
-36.22M
-13.66M
Income tax expense
-18.56M
-11.29M
-13.76M
-3.71M
Effective tax rate
25.88%
30.87%
34.20%
25.48%
Other operating expenses
43.80M
31.96M
23.04M
10.48M
Net income
-49.51M
-24.80M
-24.79M
-18.09M
Net profit margin
-74.31%
-28.83%
-45.65%
-24.84%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-11.96M
-10.77M
-7.18M
-6.50M
Net interest expenses
-11.96M
-10.77M
-7.18M
-6.50M
Depreciation and amortization charges
6.06M
4.68M
4.76M
4.77M
EBITDA
-54.06M
-52.53M
-24.04M
-2.10M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer